According to the company, its Radix Isatidis dispersible tablets, a herbal-based traditional Chinese medicine, received the highest number of orders, over 60% of the total value of the purchase orders.
Cao Wubo, chairman and CEO of Genesis Pharmaceuticals, said: “We believe that these new purchase orders from these distributors will increase our presence in the Chinese over-the-counter pharmaceuticals market. We hope to expand our market share and get even greater brand recognition in China in the future by bringing new and innovative products to market.”